1. Home
  2. CTNT vs DCOY Comparison

CTNT vs DCOY Comparison

Compare CTNT & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTNT

Cheetah Net Supply Chain Service Inc.

HOLD

Current Price

$1.73

Market Cap

4.9M

Sector

N/A

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$6.11

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTNT
DCOY
Founded
2016
N/A
Country
United States
United States
Employees
N/A
11
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
4.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
CTNT
DCOY
Price
$1.73
$6.11
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
1.2M
240.7K
Earning Date
05-08-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
57.74
N/A
EPS
N/A
N/A
Revenue
$1,288,536.00
N/A
Revenue This Year
$42.49
N/A
Revenue Next Year
$22.22
N/A
P/E Ratio
N/A
N/A
Revenue Growth
182.69
N/A
52 Week Low
$0.02
$0.53
52 Week High
$4.21
$13.51

Technical Indicators

Market Signals
Indicator
CTNT
DCOY
Relative Strength Index (RSI) 49.76 44.91
Support Level $1.48 $5.08
Resistance Level $1.91 $6.47
Average True Range (ATR) 0.18 1.25
MACD 0.01 -0.11
Stochastic Oscillator 53.76 2.99

Price Performance

Historical Comparison
CTNT
DCOY

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: